Exact Mass: 564.3814542

Exact Mass Matches: 564.3814542

Found 83 metabolites which its exact mass value is equals to given mass value 564.3814542, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

PA(8:0/18:0)

[(2R)-2-(octadecanoyloxy)-3-(octanoyloxy)propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(8:0/18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/18:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of stearic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(10:0/i-16:0)

[(2R)-3-(decanoyloxy)-2-[(14-methylpentadecanoyl)oxy]propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(10:0/i-16:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(10:0/i-16:0), in particular, consists of one chain of capric acid at the C-1 position and one chain of isohexadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(8:0/i-18:0)

[(2R)-2-[(16-methylheptadecanoyl)oxy]-3-(octanoyloxy)propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(8:0/i-18:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(8:0/i-18:0), in particular, consists of one chain of caprylic acid at the C-1 position and one chain of isooctadecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-13:0/a-13:0)

[(2R)-2-(10-methyldodecanoyloxy)-3-phosphonooxypropyl] 10-methyldodecanoate

C29H57O8P (564.3790852)


PA(a-13:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/a-13:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(a-13:0/i-13:0)

[(2R)-3-[(10-methyldodecanoyl)oxy]-2-[(11-methyldodecanoyl)oxy]propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(a-13:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(a-13:0/i-13:0), in particular, consists of one chain of anteisotridecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-12:0/i-14:0)

[(2R)-2-[(12-methyltridecanoyl)oxy]-3-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(i-12:0/i-14:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-12:0/i-14:0), in particular, consists of one chain of isododecanoic acid at the C-1 position and one chain of isotetradecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-13:0/a-13:0)

[(2R)-2-[(10-methyldodecanoyl)oxy]-3-[(11-methyldodecanoyl)oxy]propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(i-13:0/a-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/a-13:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of anteisotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-13:0/i-13:0)

[(2R)-2-(11-methyldodecanoyloxy)-3-phosphonooxypropyl] 11-methyldodecanoate

C29H57O8P (564.3790852)


PA(i-13:0/i-13:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-13:0/i-13:0), in particular, consists of one chain of isotridecanoic acid at the C-1 position and one chain of isotridecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

PA(i-14:0/i-12:0)

[(2R)-3-[(12-methyltridecanoyl)oxy]-2-[(10-methylundecanoyl)oxy]propoxy]phosphonic acid

C29H57O8P (564.3790852)


PA(i-14:0/i-12:0) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(i-14:0/i-12:0), in particular, consists of one chain of isotetradecanoic acid at the C-1 position and one chain of isododecanoic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids.

   

Cholylarginine

5-Carbamimidamido-2-[(1-hydroxy-4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0,.0,]heptadecan-14-yl}pentylidene)amino]pentanoate

C30H52N4O6 (564.3886652)


Cholylarginine belongs to a class of molecules known as bile acid-amino acid conjugates. These are bile acid conjugates that consist of a primary bile acid such as cholic acid, doxycholic acid and chenodeoxycholic acid, conjugated to an amino acid. Cholylarginine consists of the bile acid cholic acid conjugated to the amino acid Arginine conjugated at the C24 acyl site.Bile acids play an important role in regulating various physiological systems, such as fat digestion, cholesterol metabolism, vitamin absorption, liver function, and enterohepatic circulation through their combined signaling, detergent, and antimicrobial mechanisms (PMID: 34127070). Bile acids also act as detergents in the gut and support the absorption of fats through the intestinal membrane. These same properties allow for the disruption of bacterial membranes, thereby allowing them to serve a bacteriocidal or bacteriostatic function. In humans (and other mammals) bile acids are normally conjugated with the amino acids glycine and taurine by the liver. This conjugation catalyzed by two liver enzymes, bile acid CoA ligase (BAL) and bile acid CoA: amino acid N-acyltransferase (BAT). Glycine and taurine bound BAs are also referred to as bile salts due to their decreased pKa and complete ionization resulting in these compounds being present as anions in vivo. Unlike glycine and taurine-conjugated bile acids, these recently discovered bile acids, such as Cholylarginine, are produced by the gut microbiota, making them secondary bile acids (PMID: 32103176) or microbially conjugated bile acids (MCBAs) (PMID: 34127070). Evidence suggests that these bile acid-amino acid conjugates are produced by microbes belonging to Clostridia species (PMID: 32103176). These unusual bile acid-amino acid conjugates are found in higher frequency in patients with inflammatory bowel disease (IBD), cystic fibrosis (CF) and in infants (PMID: 32103176). Cholylarginine appears to act as an agonist for the farnesoid X receptor (FXR) and it can also lead to reduced expression of bile acid synthesis genes (PMID: 32103176). It currently appears that microbially conjugated bile acids (MCBAs) or amino acid-bile acid conjugates are only conjugated to cholic acid, deoxycholic acid and chenodeoxycholic acid (PMID: 34127070). It has been estimated that if microbial conjugation of bile acids is very promiscuous and occurs for all potential oxidized, epimerized, and dehydroxylated states of each hydroxyl group present on cholic acid (C3, C7, C12) in addition to ring orientation, the total number of potential human bile acid conjugates could be over 2800 (PMID: 34127070).

   
   
   

Arginine conjugated cholic acid

Arginine conjugated cholic acid

C30H52N4O6 (564.3886652)


   

PA(14:0/12:0)

1-tetradecanoyl-2-dodecanoyl-glycero-3-phosphate

C29H57O8P (564.3790852)


   

PA(13:0/13:0)

1,2-ditridecanoyl-sn-glycero-3-phosphate

C29H57O8P (564.3790852)


   

PA(12:0/14:0)

1-dodecanoyl-2-tetradecanoyl-glycero-3-phosphate

C29H57O8P (564.3790852)


   

N-arachidoyl-O-phosphocholineserine

N-eicosanoyl-O-phosphocholine-L-serine

C28H57N2O7P (564.3903181999999)


   

PA 26:0

1-dodecanoyl-2-tetradecanoyl-glycero-3-phosphate

C29H57O8P (564.3790852)


   

2,2-bis(hydroxymethyl)propane-1,3-diol,octadecanoic acid,prop-2-enoic acid

2,2-bis(hydroxymethyl)propane-1,3-diol,octadecanoic acid,prop-2-enoic acid

C29H56O10 (564.3873276)


   

(1r)-2-(Dodecanoyloxy)-1-[(Phosphonooxy)methyl]ethyl Tetradecanoate

(1r)-2-(Dodecanoyloxy)-1-[(Phosphonooxy)methyl]ethyl Tetradecanoate

C29H57O8P (564.3790852)


   

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] hexadecanoate

[(2R)-2-decanoyloxy-3-phosphonooxypropyl] hexadecanoate

C29H57O8P (564.3790852)


   
   
   
   
   
   
   
   
   
   
   

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tricosanoate

(1-Phosphonooxy-3-propanoyloxypropan-2-yl) tricosanoate

C29H57O8P (564.3790852)


   

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

(1-Pentanoyloxy-3-phosphonooxypropan-2-yl) henicosanoate

C29H57O8P (564.3790852)


   

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

(1-Heptanoyloxy-3-phosphonooxypropan-2-yl) nonadecanoate

C29H57O8P (564.3790852)


   

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

(1-Octanoyloxy-3-phosphonooxypropan-2-yl) octadecanoate

C29H57O8P (564.3790852)


   

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

(1-Hexanoyloxy-3-phosphonooxypropan-2-yl) icosanoate

C29H57O8P (564.3790852)


   

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

(1-Nonanoyloxy-3-phosphonooxypropan-2-yl) heptadecanoate

C29H57O8P (564.3790852)


   

(1-Acetyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

(1-Acetyloxy-3-phosphonooxypropan-2-yl) tetracosanoate

C29H57O8P (564.3790852)


   

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

(1-Butanoyloxy-3-phosphonooxypropan-2-yl) docosanoate

C29H57O8P (564.3790852)


   

(3-Phosphonooxy-2-tridecanoyloxypropyl) tridecanoate

(3-Phosphonooxy-2-tridecanoyloxypropyl) tridecanoate

C29H57O8P (564.3790852)


   

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate

(1-Decanoyloxy-3-phosphonooxypropan-2-yl) hexadecanoate

C29H57O8P (564.3790852)


   

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) pentadecanoate

(1-Phosphonooxy-3-undecanoyloxypropan-2-yl) pentadecanoate

C29H57O8P (564.3790852)


   

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

(1-Dodecanoyloxy-3-phosphonooxypropan-2-yl) tetradecanoate

C29H57O8P (564.3790852)


   

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] pentadecanoate

[(2R)-1-phosphonooxy-3-undecanoyloxypropan-2-yl] pentadecanoate

C29H57O8P (564.3790852)


   

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] pentadecanoate

[(2R)-3-phosphonooxy-2-undecanoyloxypropyl] pentadecanoate

C29H57O8P (564.3790852)


   

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(4E,7E)-deca-4,7-dienoyl]oxy-2-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(E)-dec-4-enoyl]oxy-3-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] hexadecanoate

[(2R)-1-decanoyloxy-3-phosphonooxypropan-2-yl] hexadecanoate

C29H57O8P (564.3790852)


   

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[3-[(E)-dec-4-enoyl]oxy-2-[(3E,6E,9E)-dodeca-3,6,9-trienoyl]oxypropoxy]propyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4E,7E)-deca-4,7-dienoyl]oxy-3-[(6E,9E)-dodeca-6,9-dienoyl]oxypropoxy]propyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[3-[3-acetyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

[3-[3-acetyloxy-2-[(8Z,11Z,14Z,17Z)-icosa-8,11,14,17-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[3-[3-butanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

[3-[3-butanoyloxy-2-[(6Z,9Z,12Z,15Z)-octadeca-6,9,12,15-tetraenoyl]oxypropoxy]-1-carboxypropyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

[1-carboxy-3-[2-[(4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoyl]oxy-3-hexanoyloxypropoxy]propyl]-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

2-[carboxy-[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

2-[carboxy-[3-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxy-2-hydroxypropoxy]methoxy]ethyl-trimethylazanium

C32H54NO7+ (564.3900074000001)


   

1-tetradecanoyl-2-dodecanoyl-glycero-3-phosphate

1-tetradecanoyl-2-dodecanoyl-glycero-3-phosphate

C29H57O8P (564.3790852)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

10-hydroxy-6a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

10-hydroxy-6a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H52O5 (564.3814542)


   

(2r)-n-[(2s)-6-[(1-acetylcyclopropyl)-c-hydroxycarbonimidoyl]-5-oxohexan-2-yl]-2-[(1-hydroxytetradecylidene)amino]butanediimidic acid

(2r)-n-[(2s)-6-[(1-acetylcyclopropyl)-c-hydroxycarbonimidoyl]-5-oxohexan-2-yl]-2-[(1-hydroxytetradecylidene)amino]butanediimidic acid

C30H52N4O6 (564.3886652)


   

(1s,2r,4as,6ar,6br,8as,10s,12ar,12bs,14br)-10-hydroxy-4a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-6a-carboxylic acid

(1s,2r,4as,6ar,6br,8as,10s,12ar,12bs,14br)-10-hydroxy-4a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-6a-carboxylic acid

C36H52O5 (564.3814542)


   

(1s,2r,4as,6ar,6br,8as,10s,12ar,12br,14br)-10-hydroxy-6a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

(1s,2r,4as,6ar,6br,8as,10s,12ar,12br,14br)-10-hydroxy-6a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-4a-carboxylic acid

C36H52O5 (564.3814542)


   

10-hydroxy-4a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-6a-carboxylic acid

10-hydroxy-4a-(4-hydroxyphenoxymethyl)-1,2,6b,9,9,12a-hexamethyl-2,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydro-1h-picene-6a-carboxylic acid

C36H52O5 (564.3814542)